Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 1122-1128

  Iizuka, Koho ^a,d   Nakajima, Chigusa ^b   Iizuka, Yoshie Matsubayashi ^a   Takase, Mitsuyo ^b   Kato, Takako ^b   Noda, Satoshi ^c   Tanaka, Kazuo ^c   Kanagawa, Osami ^b,e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Mayo Mail Code 806   (United States)

^e NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; NATURAL KILLER CELL RECEPTOR; CD3 ANTIGEN, ZETA CHAIN; IMMUNOGLOBULIN RECEPTOR; LECTIN; LY 49 ANTIGEN; LY ANTIGEN; LY-49 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CYTOMEGALOVIRUS INFECTION; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; GENETIC ENGINEERING; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; LETHALITY; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; BETAHERPESVIRINAE; BIOSYNTHESIS; CHIMERA; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; METHODOLOGY; POLYMERASE CHAIN REACTION; PROTEIN ENGINEERING; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD3; ANTIGENS, LY; CD8-POSITIVE T-LYMPHOCYTES; CHIMERA; HERPESVIRIDAE INFECTIONS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; POLYMERASE CHAIN REACTION; PROTEIN ENGINEERING; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC;

EID: 34548782000     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.1122     Document Type: Article

References (45)

1. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
2. Scalzo, A. A., N. A. Fitzgerald, C. R. Wallace, A. E. Gibbons, Y. C. Smart, R. C. Burton, and G. R. Shellam. 1992. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149: 581-589.
3. Fishman, J. A., and R. H. Rubin. 1998. Infection in organ-transplant recipients. N. Engl. J. Med. 338: 1741-1751.
4. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18: 861-926.
5. Webb, J. R., S. H. Lee, and S. M. Vidal. 2002. Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun. 3: 250-262.
6. Beutler, B., K. Hoebe, X. Du, E. Janssen, P. Georgel, and K. Tabeta. 2003. Lps2 and signal transduction in sepsis: at the intersection of host responses to bacteria and viruses. Scand. J. Infect. Dis. 35: 563-567.
7. Krug, A., A. R. French, W. Barchet, J. A. Fischer, A. Dzionek, J. T. Pingel, M. M. Orihuela, S. Akira, W. M. Yokoyama, and M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21: 107-119.
8. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101: 3516-3521.
9. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
10. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
11. Yokoyama, W. M., and B. F. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3: 304-316.
12. Bubic, I., M. Wagner, A. Krmpotic, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjic, and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78: 7536-7544.
13. Lee, S. H., S. Girard, D. Macina, M. Busa, A. Zafer, A. Belouchi, P. Gros, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42-45.
14. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
15. Lee, S. H., A. Zafer, Y. de Repentigny, R. Kothary, M. L. Tremblay, P. Gros, P. Duplay, J. R. Webb, and S. M. Vidal. 2003. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197: 515-526.
16. Loh, J., D. T. Chu, A. K. O'Guin, W. M. Yokoyama, and H. W. Virgin IV. 2005. Natural killer cells utilize both perforin and γ interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79: 661-667.
17. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
18. Lanier, L. L., B. C. Cortiss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
19. Olcese, L., A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, and E. Vivier. 1997. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158: 5083-5086.
20. 2-microglobulin-deficient mice. J. Immunol. 169: 126-136.
21. Iizuka, K., O. V. Naidenko, B. F. Plougastel, D. H. Fremont, and W. M. Yokoyama. 2003. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4: 801-807.
22. Fujio, K., Y. Misaki, K. Setoguchi, S. Morita, K. Kawahata, I. Kato, T. Nosaka, K. Yamamoto, and T. Kitamura. 2000. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the αβ TCR complex. J. Immunol. 165: 528-532.
23. Koga, Y., K. Tanaka, Y. Y. Lu, M. Oh-Tsu, M. Sasaki, G. Kimura, and K. Nomoto. 1994. Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J. Virol. 68: 4322-4328.
24. Jordan, M. C., and J. L. Takagi. 1983. Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect. Immun. 41: 841-843.
25. French, A. R., J. T. Pingel, M. Wagner, I. Bubic, L. Yang, S. Kim, U. Koszinowski, S. Jonjic, and W. M. Yokoyama. 2004. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20: 747-756.
26. + IL-2-activated natural killer cells. Nature 358: 66-70.
27. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631.
28. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
29. Riddell, S. R., and P. D. Greenberg. 1990. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods 128: 189-201.
30. Engers, H. D., G. D. Sorenson, G. Terres, A. L. Glasebrook, C. Horvath, and K. T. Brunner. 1981. Functional activity in vivo of cytolytic T lymphocytes generated in vitro. In Mechanisms of Lymphocyte Activation. K. Resh and H. Kirchner, eds. Elsevier/North-Holland, Amsterdam, p. 632.
31. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480.
32. + T cells after acute infection. Nat. Immunol. 5: 927-933.
33. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
34. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
35. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22: 765-787.
36. + T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment. J. Immunol. 172: 7315-7323.
37. Rabinovich, B. A., J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R. G. Miller. 2003. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170: 3572-3576.
38. Cerboni, C., A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni. Antigen-activated human T lymphocytes express cell surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK cell lysis. Blood. In Press.
39. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
40. Guma, M., A. Angulo, and M. Lopez-Botet. 2006. NK cell receptors involved in the response to human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 298: 207-223.
41. Alter, G., and M. Altfeld. 2006. NK cell function in HIV-1 infection. Curr. Mol. Med. 6: 621-629.
42. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
43. McQueen, K. L., and P. Parham. 2002. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14: 615-621.
44. Trowsdale, J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15: 363-374.
45. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7: 517-523.